Pay in 4 interest-free payments of $36.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4
Nielsen AN
Formula: C19H32O2
To test whether GSTO1-IN-1 had in vivo efficacy
injury and HCC also occur if hepatic S-Adenosyl-L-methionine level is excessive chronically
Aficamten - CAS# 2364554-48-1 Catalog No.:M33502-2 35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4Aficamten, CAS No. 2364554 48 1, also known as CK 3773274 and CK 274, is a Next Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy. Aficamten was designed to provide a predicted human half life (t1 2) appropriate for once a day (qd) dosing, to reach steady state within two weeks, to have no substantial cytochrome P450 induction or inhibition, and to have a wide therapeutic window in vivo with a clear pharmacokinetic
US$ 44.00
US$ 55.00
US$ 23.00
US$ 10.00
US$ 72.00